Comparison of Three Modalities of Feeding in Preterm Infants ≤32 Weeks and ≤1,250 G: A Randomized Controlled Trial

被引:1
作者
Kumar, Vijay [1 ,2 ]
Thakur, Anup [3 ]
Garg, Pankaj [3 ]
Kler, Neelam [3 ,4 ]
机构
[1] Inst Med Sci, Dept Neonatol, Bhubaneswar, Orissa, India
[2] Sum Hosp, Bhubaneswar, Orissa, India
[3] Sir Ganga Ram Hosp, Dept Neonatol, New Delhi, India
[4] Sir Ganga Ram Hosp, Dept Neonatol, New Delhi 110060, India
关键词
feeding intolerance; growth velocity; very low birth weight infants; feeding methods; LOW-BIRTH-WEIGHT; INTERMITTENT BOLUS; NECROTIZING ENTEROCOLITIS; PREMATURE-INFANTS; HUMAN-MILK; TOLERANCE; RESPONSES; GROWTH;
D O I
10.1055/a-2074-1960
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Early establishment of enteral feeds is desirable in very preterm infants, but it may be associated with feeding intolerance. Several feeding methods have been studied with no strong evidence to suggest the preferred feeding method to establish early full enteral feeds. We studied three modalities of feeding in preterm infants <= 32 weeks and <= 1,250 g: continuous infusion (CI), intermittent bolus by infusion (IBI), and intermittent bolus by gravity (IBG) for their effect on time to reach full enteral feeds of 180 mL/kg/d. Study Design We randomized 146 infants, 49 infants in each CI and IBI group and 48 infants in the IBG group. In the CI group, feeds were delivered by an infusion pump continuously over 24 hours. In the IBI group, feeds were given every 2 hours and infused over 15 minutes by an infusion pump. In the IBG group, feeds were delivered by gravity over 10 to 30 minutes. The intervention was continued till infants reached direct breast/cup feeds. Results The mean (standard deviation) gestation in CI, IBI, and IBG groups were 28.4 (2.2), 28.5(1.9), and 28.6 (1.8) weeks, respectively. The time to reach full feeds in CI, IBI, and IBG were not significantly different (median [interquartile range]: 13 [10-16], 11.5 [9-17], and 13 [9.5-14.2] d, respectively, p = 0.71). The proportions of infants who developed feeding intolerance in CI, IBI, and IBG were similar (n [%]: 21 [51.2%], 20 [52.6%], and 22 [64.7%], respectively, p = 0.45). There was no difference in necrotizing enterocolitis >= 2 (p = 0.80), bronchopulmonary dysplasia (p = 0.86), intraventricular hemorrhage >= 2 (p = 0.35), patent ductus arteriosus requiring treatment (p = 0.44), retinopathy of prematurity requiring treatment (p = 0.51), and growth parameters at discharge. Conclusion In preterm infants, <= 32 weeks of gestation and birth weight <= 1,250 g, there was no difference in time to reach full enteral feeds in the three modalities of feeding. This study is registered with Clinical Trials Registry India (CTRI) and the registration number is CTRI/2017/06/008792.
引用
收藏
页码:e1792 / e1799
页数:8
相关论文
共 46 条
  • [41] Feeding preterm infants milk with a higher dose of docosahexaenoic acid than that used in current practice does not influence language or behavior in early childhood: a follow-up study of a randomized controlled trial
    Smithers, Lisa G.
    Collins, Carmel T.
    Simmonds, Lucy A.
    Gibson, Robert A.
    McPhee, Andrew
    Makrides, Maria
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2010, 91 (03) : 628 - 634
  • [42] Efficacy of Bifidobacterium longum, B. infantis and Lactobacillus acidophilus probiotics to prevent gut dysbiosis in preterm infants of 28+0-32+6 weeks of gestation: a randomised, placebo-controlled, double-blind, multicentre trial: the PRIMAL Clinical Study protocol
    Marissen, Janina
    Haiss, Annette
    Meyer, Claudius
    Van Rossum, Thea
    Buente, Lisa Marie
    Frommhold, David
    Gille, Christian
    Goedicke-Fritz, Sybelle
    Goepel, Wolfgang
    Hudalla, Hannes
    Pagel, Julia
    Pirr, Sabine
    Siller, Bastian
    Viemann, Dorothee
    Vens, Maren
    Koenig, Inke
    Herting, Egbert
    Zemlin, Michael
    Gehring, Stephan
    Bork, Peer
    Henneke, Philipp
    Haertel, Christoph
    BMJ OPEN, 2019, 9 (11):
  • [43] Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali
    Juho Luoma
    Laura Adubra
    Dagmar Alber
    Per Ashorn
    Ulla Ashorn
    Elaine Cloutman-Green
    Fatoumata Diallo
    Camilla Ducker
    Riku Elovainio
    Yue-Mei Fan
    Lily Gates
    Gwydion Gruffudd
    Tiia Haapaniemi
    Fadima Haidara
    Lotta Hallamaa
    Rikhard Ihamuotila
    Nigel Klein
    Owen Martell
    Samba Sow
    Taru Vehmasto
    Yin Bun Cheung
    Trials, 24
  • [44] Statistical analysis plan for the LAKANA trial: a cluster-randomized, placebo-controlled, double-blinded, parallel group, three-arm clinical trial testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali
    Luoma, Juho
    Adubra, Laura
    Alber, Dagmar
    Ashorn, Per
    Ashorn, Ulla
    Cloutman-Green, Elaine
    Diallo, Fatoumata
    Ducker, Camilla
    Elovainio, Riku
    Fan, Yue-Mei
    Gates, Lily
    Gruffudd, Gwydion
    Haapaniemi, Tiia
    Haidara, Fadima
    Hallamaa, Lotta
    Ihamuotila, Rikhard
    Klein, Nigel
    Martell, Owen
    Sow, Samba
    Vehmasto, Taru
    Cheung, Yin Bun
    TRIALS, 2023, 24 (01)
  • [45] Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1–11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial
    Laura Adubra
    Dagmar Alber
    Per Ashorn
    Ulla Ashorn
    Yin Bun Cheung
    Elaine Cloutman-Green
    Fatoumata Diallo
    Camilla Ducker
    Riku Elovainio
    Yue-Mei Fan
    Lily Gates
    Gwydion Gruffudd
    Tiia Haapaniemi
    Fadima Haidara
    Lotta Hallamaa
    Rikhard Ihamuotila
    Nigel Klein
    Juho Luoma
    Owen Martell
    Samba Sow
    Taru Vehmasto
    Trials, 24
  • [46] Testing the effects of mass drug administration of azithromycin on mortality and other outcomes among 1-11-month-old infants in Mali (LAKANA): study protocol for a cluster-randomized, placebo-controlled, double-blinded, parallel-group, three-arm clinical trial
    Adubra, Laura
    Alber, Dagmar
    Ashorn, Per
    Ashorn, Ulla
    Cheung, Yin Bun
    Cloutman-Green, Elaine
    Diallo, Fatoumata
    Ducker, Camilla
    Elovainio, Riku
    Fan, Yue-Mei
    Gates, Lily
    Gruffudd, Gwydion
    Haapaniemi, Tiia
    Haidara, Fadima
    Hallamaa, Lotta
    Ihamuotila, Rikhard
    Klein, Nigel
    Luoma, Juho
    Martell, Owen
    Sow, Samba
    Vehmasto, Taru
    TRIALS, 2023, 24 (01)